Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
AN ASSESSMENT OF THE SERIOUS INFECTION RATE IN RITUXIMAB-TREATED RHEUMATOID ARTHRITIS (RA) PATIENTS WHO SUBSEQUENTLY RECEIVED OTHER BIOLOGIC THERAPIES: A FOLLOW-UP FROM RITUXIMAB CLINICAL TRIALS Genovese, M. C., Breedveld, F. C., Emery, P., Cohen, S. B., Keystone, E. C., Matteson, E. L., Burke, L. S., Chai, A., Reiss, W. G., Sweetser, M. T., Shaw, T. M. OXFORD UNIV PRESS. 2010: I4
View details for Web of Science ID 000276047500008